MaxCyte, Inc.

MaxCyte, Inc.

Let's Build Better Cells Together

Founded 1999

Rockville, United States 138 employees Venture round Total: $30.50M Biotechnology, Manufacturing +1

MaxCyte, Inc. is a biotechnology and manufacturing company that focuses on cell engineering to enhance the potential of cells for the betterment of patients’ lives. Established in 1998 and headquartered in the United States, MaxCyte has dedicated over two decades to refine its expertise in transfection workflow and develop the ExPERT™ platform, based on Flow Electroporation technology. This platform is tailored to support the rapidly expanding cell therapy market, covering the entire spectrum from discovery and development to the commercialization of next-generation, cell-based medicines. MaxCyte's last investment was a significant $1.70M Venture Round in December 16, 2014. The company's investment was crucial in advancing its pioneering technology and further strengthening its position in the market. MaxCyte's commitment to innovation and excellence is reflected in its slogan, "Let's Build Better Cells Together." The company's vision is to maximize the potential of cells to improve lives while its mission is centered on building trust with customers and leveraging best-in-class technology and expertise to address the most challenging issues in cell engineering. MaxCyte's core values underscore its dedication to respecting its partners and patients, as well as its unwavering commitment to mitigating the burden of disease. The company's ethos of collaboration, curiosity, and compassion aligns with the ever-evolving landscape of biotechnology and manufacturing, positioning MaxCyte as a significant player in the industry.

Funding Stage	Amount	Investors	Lead Investors	Date
Venture Round	$1.70M	-		16 Dec 2014
Venture Round	$1.50M	-		31 Aug 2009
Venture Round	$2.12M	-		01 Oct 2008
Venture Round	$1.14M	-		29 Oct 2007
Venture Round	$8.17M	-		29 Sep 2006
Venture Round	$3.43M	-		28 Apr 2005
Series B	$10.70M	3	Intersouth Partners, Harbert Growth Partners +1	24 Mar 2004
Series A	$1.75M	-		18 Dec 2002

Funding Stage

Amount

Investors

Lead Investors

Date

Venture Round

$1.70M

16 Dec 2014

Venture Round

$1.50M

31 Aug 2009

Venture Round

$2.12M

01 Oct 2008

Venture Round

$1.14M

29 Oct 2007

Venture Round

$8.17M

29 Sep 2006

Venture Round

$3.43M

28 Apr 2005

Series B

$10.70M

Intersouth Partners, Harbert Growth Partners +1

24 Mar 2004

Series A

$1.75M

18 Dec 2002

FAQ About MaxCyte, Inc.

Let's Build Better Cells Together

MaxCyte, Inc. was founded in 1999.

MaxCyte, Inc. is headquartered in Rockville, United States.

MaxCyte, Inc. operates in Biotechnology, Manufacturing and Medical Devices. Its work centres on Cell Engineering, Transfection Workflow, Flow Electroporation Technology and Cell Therapy Market.

MaxCyte, Inc. has approximately 138 employees.

MaxCyte, Inc. has completed 8 funding rounds, raising a total of $30.50M. The latest funding stage is Venture round.

Top alternatives and competitors to MaxCyte, Inc. include StemCo Biomedical, Aglaris Ltd Group, China Regenerative Medicine International, AIVITA Biomedical, Inc., Fibralign Corporation. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

MaxCyte, Inc. and StemCo Biomedical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About MaxCyte, Inc.

Funding Rounds & Investors (8)

MaxCyte, Inc. Alternatives & Competitors

FAQ About MaxCyte, Inc.